Identification of key genes and pathways in benign prostatic hyperplasia
- 4 April 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (11) , 19942-19950
Abstract
Benign prostatic hyperplasia (BPH) is one of the most common causes of lower urinary tract symptoms (LUTS) in elderly man. However, the underlying molecular mechanisms of BPH have not been completely elucidated. We identified the key genes and pathways by using analysis of Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were identified using edgeR. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed for the DEGs by Database for Annotation, Visualization and Integrated Discovery (DAVID) database and ConsensusPathDB, respectively. Then, protein–protein interaction (PPI) networks were established by the Search Tool for the Retrieval of Interacting Genes (STRING) database and visualized by Cytoscape software. Finally, we identified 660 DEGs ultimately including 268 upregulated genes and 392 downregulated genes. GO analysis revealed that DEGs were mainly enriched in extracellular exosome, identical protein binding, mitochondrial adenosine triphosphate (ATP) synthesis coupled proton transport, extracelluar matrix, focal adhesion, cytosol, Golgi apparatus, cytoplasm, protein binding, and Golgi membrane. Focal adhesion pathway, FoxO signaling pathway, and autophagy pathway were selected. Ubiquitin‐conjugating enzyme E2 C (UBE2C), serine/threonine kinase (AKT1), mitogen‐activated protein kinase 1 (MAPK1), cyclin B1 (CCNB1), polo‐like kinase 1 (PLK1) were filtrated as the hub genes according to the degree of connectivity from the PPI network. The five hub genes including UBE2C, AKT1, MAPK1, CCNB1, PLK1 may play key roles in the pathogenesis of benign prostatic hyperplasia (BPH). Focal adhesion pathway, FoxO signaling pathway, and autophagy pathway may be crucial for the progression of BPH.Keywords
This publication has 31 references indexed in Scilit:
- Deregulation of ATG9A by impaired AR signaling induces autophagy in prostate stromal fibroblasts and promotes BPH progressionCell Death & Disease, 2018
- Correlation between Cholinergic Innervation, Autophagy, and Etiopathology of Benign Prostatic HyperplasiaChinese Medical Journal, 2017
- MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivoTumor Biology, 2015
- Mitochondria-dependent apoptogenic activity of the aqueous root extract of Croton membranaceus against human BPH-1 cellsGenetics and Molecular Research, 2015
- The Role of Inflammation in Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH) and Its Potential Impact on Medical TherapyCurrent Urology Reports, 2014
- Inhibition of smooth muscle force generation by focal adhesion kinase inhibitors in the hyperplastic human prostateAmerican Journal of Physiology-Renal Physiology, 2014
- Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancerCancer Biology & Therapy, 2014
- Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancerOncogene, 2013
- Akt1 is the principal Akt isoform regulating apoptosis in limiting cytokine concentrationsCell Death & Differentiation, 2013
- Estrogen and androgen signaling in the pathogenesis of BPHNature Reviews Urology, 2011